Biosim makers scored a big win Monday as the Supreme Court ruled with Sandoz in a much-watched legal dispute with Amgen. The landmark decision, set to leave a distinct mark on the budding field, allows biosim makers to give marketing notice before FDA approval, meaning their products can launch faster.
In landmark Amgen v. Sandoz ruling, biosim makers can give notice before FDA nod
Leave a Comment